Outlook Therapeutics Inc (OTLK)

Oct 13, 2025

News impact scoring models applied to Outlook Therapeutics Inc.2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Can Outlook Therapeutics Inc. stock beat analyst upgradesQuarterly Performance Summary & Technical Pattern Based Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Can Outlook Therapeutics Inc. stock continue upward trendJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com

Oct 13, 2025

Oct 13, 2025

Full technical analysis of Outlook Therapeutics Inc. stockJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

What earnings revisions data tells us about Outlook Therapeutics Inc. - newser.com

Oct 13, 2025

Oct 12, 2025

Real time pattern detection on Outlook Therapeutics Inc. stockBull Run & Verified Stock Trade Ideas - newser.com

Oct 12, 2025

Oct 12, 2025

Applying sector rotation models to Outlook Therapeutics Inc.Bear Alert & Verified Trade Idea Suggestions - newser.com

Oct 12, 2025

Oct 12, 2025

Is Outlook Therapeutics Inc. (41ON) stock good for long term investingEarnings Summary Report & AI Driven Stock Movement Reports - newser.com

Oct 12, 2025

Oct 11, 2025

Is Outlook Therapeutics Inc a good long term investmentStock Buyback Announcements & Exceptional Trading Strategies - earlytimes.in

Oct 11, 2025

Oct 10, 2025

How sentiment analysis helps forecast Outlook Therapeutics Inc.M&A Rumor & Real-Time Sentiment Analysis - newser.com

Oct 10, 2025

Oct 10, 2025

What does recent volatility data suggest for Outlook Therapeutics Inc.July 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Outlook Therapeutics Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Oncobiologics (NASDAQ:OTLK) - MarketBeat

Oct 10, 2025

Oct 10, 2025

How Outlook Therapeutics Inc. (41ON) stock expands through international marketsWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com

Oct 10, 2025

Oct 10, 2025

Can Outlook Therapeutics Inc. rally from current levels2025 Sector Review & Stock Portfolio Risk Control - newser.com

Oct 10, 2025

Oct 09, 2025

How Outlook Therapeutics Inc. stock performs in interest rate cyclesQuarterly Profit Review & Weekly High Potential Stock Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

What is the fair value of Outlook Therapeutics Inc. stock now2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com

Oct 09, 2025

Oct 06, 2025

Market reaction to Outlook Therapeutics Inc.’s recent newsShare Buyback & Safe Entry Point Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Will Outlook Therapeutics Inc. (41ON) stock outperform value peersJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com

Oct 06, 2025

Oct 06, 2025

How to recover losses in Outlook Therapeutics Inc. stockJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com

Oct 06, 2025

Oct 05, 2025

Sentiment analysis tools applied to Outlook Therapeutics Inc.July 2025 Retail & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

How Outlook Therapeutics Inc. (41ON) stock moves in volatile trading sessionsJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com

Oct 05, 2025

Oct 03, 2025

Why Outlook Therapeutics Inc. (41ON) stock is favored by hedge fundsPortfolio Return Report & Low Risk High Win Rate Picks - newser.com

Oct 03, 2025

Oct 02, 2025

Is Outlook Therapeutics Inc. (41ON) stock attractive for growth fundsEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com

Oct 02, 2025

Oct 02, 2025

Outlook To Resubmit Ophthalmic Bevacizumab To The FDA By Year End - insights.citeline.com

Oct 02, 2025

Sep 30, 2025

OTLK Receives Neutral Rating from HC Wainwright & Co. | OTLK Sto - GuruFocus

Sep 30, 2025

Sep 30, 2025

H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock - Investing.com India

Sep 30, 2025

Sep 30, 2025

H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 30, 2025

HC Wainwright & Co. Reiterates Outlook Therapeutics (OTLK) Neutral Recommendation - Nasdaq

Sep 30, 2025